Aspirin on trial

A trial into the effects of aspirin on people at risk from heart disease or strokes is under way in Lanarkshire, which has the highest death rate from heart disease in Scotland.

Edinburgh University's department of public health sciences is coordinating the trial, backed by Pounds 1 million from the British Heart Foundation and the Scottish Office. Although aspirin is a well-established treatment for patients following a heart attack, it is not clear whether it also helps people considered at high risk of cardiovascular disease but with no symptoms. About 20,000 men and women over 50 with no symptoms will be screened for narrowing of the arteries, and about 3,300 with evidence of disease will be given either aspirin or a dummy pill over five years. This will determine whether future heart attacks and strokes can be prevented through early detection and treatment with low-dose aspirin.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Featured Jobs

Head of Research Support Services UNIVERSITY OF LEICESTER
Learning Enhancement Manager UNIVERSITY OF DERBY

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

Universities to scale back liberal arts and social science courses

  • David Humphries illustration (24 September 2015)

A Russell Group tagline rap is further proof that we need to reform the academy’s approach, argues Philip Moriarty

  • World University Rankings

US continues to lose its grip as institutions in Europe up their game

  • World University Rankings 2015-2016 methodology

Change for the better: fuelled by more comprehensive data, the 2015-2016 rankings probe deeper than ever

Inspired by previous movement in 1960s, PhD students say that ‘science is not neutral’ and urge scientists to confront their assumptions